Scientist Home Future Health Ltd. (SHFH) intrinsic value & 10-year financials

Scientist Home Future Health Ltd. (SHFH) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 2 fiscal years revenue reached to $197.4K, with an average return on invested capital of -137.8%.

Graham intrinsic value
—
Share price (Oct 17, 2026)
$1.70
Market cap
$40.1M
Revenue (FY2025)
$197.4K
ROIC (10-yr avg)
-137.8%
Free cash flow (FY2025)
-$323.1K

SHFH 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $197.4K -$231.7K -$0.01 -$323.1K -117.4% -137.8%
FY2024 — — — — — —

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Scientist Home Future Health Ltd revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

Scientist Home Future Health Ltd has historically struggled to out-earn its cost of capital, averaging just -137.8% ROIC.

Over the decade, Scientist Home Future Health Ltd shows that the company has leveraged its balance sheet to sustain operations.

Benjamin Graham lens

Scientist Home Future Health Ltd is evaluated under Benjamin Graham's defensive framework using SEC EDGAR fundamentals using an 8.5 + 2g earnings multiple and a 5.1% AAA bond-yield baseline.

SHFH stock: frequently asked questions

What is the intrinsic value of Scientist Home Future Health Ltd. (SHFH) stock?

Graham's formula only works with positive earnings. Scientist Home Future Health Ltd. reported diluted EPS of -$0.01 in fiscal 2025, so no Graham value is shown. The 10-year table shows revenue and cash-flow trends instead.

Does Scientist Home Future Health Ltd. generate free cash flow?

Scientist Home Future Health Ltd. generated -$323.1K of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 0 of the last 1 reported years.

What is SHFH's return on invested capital?

Average ROIC over the last 2 fiscal years was -137.8%, and average return on equity was -431.6%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this SHFH data come from?

From Scientist Home Future Health Ltd.'s annual 10-K filings on SEC EDGAR, most recently filed Aug 11, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar perfumes, cosmetics & other toilet preparations stocks